With Dove DermaSeries, Unilever Targets Premium Personal-Care Growth
This article was originally published in The Rose Sheet
Priced at $17.99 and $18.99, the moisturizers in Unilever’s new Dove DermaSeries line are more effective than leading prescription creams, the firm says. The launch is consistent with Unilever’s stated ambition to expand its personal-care portfolio in the premium direction.
You may also be interested in...
M&A activity and organic growth have grown Unilever’s personal-care unit into a “mature” business that is gaining share globally while transforming the firm’s U.S. presence, CEO Polman said during a July 24 first-half earnings call. Still, the Anglo-Dutch firm’s personal-care sector struggled in the unstable global environment, with turnover dipping 5.5% in the first half.
As of 5 February, the Scientific Committee on Consumer Safety is evaluating use of titanium dioxide – now officially classified as a Category 2 carcinogen in the EU – in cosmetic products that can expose consumers by way of inhalation. Without a favorable SCCS opinion, the ingredient’s use in those contexts will be banned under Article 15 of the Cosmetics Regulation.